Healthcare and Pharmaceutical
Healthcare and Pharmaceutical

Artificial Intelligence in Remote Patient Monitoring Market Size, Share & Analysis Report By Offering(Solutions, Services), By Offering(Pulse Oximeter, Blood Glucose Monitoring, Weight Monitoring, Others) and Regional Forecasts, 2023 - 2030

Report ID : 3025
Date : 2024-03-29
No of Pages : 160
Format : PDF

Select Licence Type

$ 3999

$ 5499

$ 8499

Report Overview

The Artificial intelligence in remote patient monitoring market was valued at 1.86 Billion in 2022 and expected to grow at CAGR of 27.4% over forecast period.

Artificial intelligence (AI) is revolutionizing a wide range of industries, including healthcare. Remote Patient Monitoring (RPM) is one area where AI has showed tremendous promise. RPM is the use of technology to remotely monitor patients' health outside of typical healthcare settings like hospitals or clinics. Individual health profiles, history, and preferences can be used to customise patient monitoring. This tailored strategy improves RPM effectiveness by concentrating on unique patient needs, resulting in better health results.

The development of wearable devices and the Internet of Things (IoT) has simplified the collection and transmission of real-time patient health data. RPM is a viable and scalable solution for healthcare providers since AI algorithms can rapidly assess this continuous stream of data.

Offering Outlook

Based on Offering, the Artificial intelligence in remote patient monitoring market is segmented into Solutions and Services. Solutions segment accounted for largest share in 2022. The increasing need for remote healthcare services, driven by factors like an aging population, geographical barriers, and the COVID-19 pandemic, has accelerated the adoption of AI-powered RPM solutions. These technologies enable healthcare providers to monitor and manage patients' health from a distance effectively.

AI and machine learning breakthroughs have considerably improved the capabilities of RPM services. AI systems can evaluate complex patient data in real time, provide real-time insights, and help healthcare providers make data-driven decisions.

Application Outlook

Based on Application, Artificial intelligence in remote patient monitoring market is segmented into pulse oximete, blood glucose monitoring, weight monitoring, other. Pulse oximete accounted for largest market share in 2022. Pulse oximeters, in conjunction with Artificial Intelligence (AI), have emerged as a critical tool in Remote Patient Monitoring (RPM). A pulse oximeter is a non-invasive medical gadget that detects the oxygen saturation level (SpO2) and pulse rate of a patient. Pulse oximeters, when combined with AI capabilities, can provide significant insights and improve RPM efficacy.

CGM (Continuous Glucose Monitoring) sensors, which continually monitor blood glucose levels throughout the day, can be linked to AI algorithms for real-time data analysis. AI can recognize hyperglycemic (high) and hypoglycemic (low) episodes in glucose levels more effectively than typical periodic monitoring.

Regional Outlook

North America is emerged as leading market for Artificial intelligence in remote patient monitoring market in 2022.

Artificial Intelligence (AI) in Remote Patient Monitoring (RPM) is gaining traction in North America as a result of numerous factors that have aided in its adoption and expansion in the region. North America, which comprises the United States and Canada, is at the vanguard of healthcare innovation, making it a perfect location for AI-driven RPM solutions to be implemented.

Europe is expected to be the second-most prominent area in terms of Artificial intelligence in remote patient monitoring market share. European governments have been proactive in pushing digital health and artificial intelligence (AI) applications in healthcare. Regulatory organizations including as the European Medicines Agency (EMA) and the European Commission have created guidelines and procedures to encourage the development and application of artificial intelligence (AI) in healthcare, including RPM.

Artificial Intelligence (AI) in Remote Patient Monitoring (RPM) Market Report Scope

Report Attribute Details
Market  Value in 2022 USD 1.86 Billion
Forecast in 2030 USD 5.45 Billion
CAGR CAGR of 27.4% from 2023 to 2030
Base Year of forecast 2022
Historical 2018-2021
Units Revenue in USD million and CAGR from 2023 to 2030
Report  Coverage Revenue forecast, Industry outlook, competitive landscape, growth factors, and trends
Segments Scope Offering and Application
Regions Covered North America, Europe, Asia Pacific, CSA and MEA
Key Companies profiled Aicure, Biofourmis, Connect America LLC, Healthsaas Inc., Implicity., Somatix Inc., Maya Md

Global AI in Remote Patient Monitoring Market, Report Segmentation

AI in Remote Patient Monitoring Market, By Offering

  • Solutions
  • Services

AI in Remote Patient Monitoring Market, By Application

  • Pulse Oximeter
  • Blood Glucose Monitoring
  • Weight Monitoring
  • Others

AI in Remote Patient Monitoring Market, Regional Outlook

  • North America
  • U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • Spain
  • Russia
  • France
  • Italy

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

CSA

  • Brazil
  • Argentina

MEA

  • UAE
  • Saudi Arabia
  • South Africa

TABLE OF CONTENTS

EXECUTIVE SUMMARY

1       Market Overview

2       Market Drivers

3       Market Restraints

4       Market Challenges

5       Market Opportunities

5.3        Porter’s Five Analysis

5.4        Covid-19 Impact on AI in Remote Patient Monitoring industry

6       AI in Remote Patient Monitoring Market, By Offering

6.1        Solutions

6.2        Services

7       AI in Remote Patient Monitoring Market, By Application

7.1        Pulse Oximeter,

7.2        Blood Glucose Monitoring

7.3        Weight Monitoring

7.4        Others

8       Major Developments and Strategic Initiatives

9       Global AI Service providers and Product Developers

10         Market Positioning

11         Market Share Analysis

12         North America

12.1      U.S.

12.2      Canada

12.3      Mexico

13         Europe

13.1      Germany

13.2      UK

13.3      Spain

13.4      Russia

13.5      France

13.6      Italy

14         Asia Pacific

14.1      China

14.2      Japan

14.3      India

14.4      South Korea

14.5      Australia

15         CSA

15.1      Brazil

15.2      Argentina

16         MEA

16.1      UAE

16.2      Saudi Arabia

16.3      South Africa

17         Company Profiles

17.1      Biofourmis

17.1.1       Company Overview

17.1.2       Financial Performance

17.1.3       Product Portfolio

17.1.4       Strategic Initiatives

17.2      . Aicure

17.3      Care.Ai Inc.

17.4      Connect America LLC

17.5      Current health

17.6      Implicity

17.7      Maya MD

17.8      Thryv

17.9      Somnatix Inc.

17.10        Healthsaas

n/a

n/a